Bioorganic Chemistry Division, Indian Institute of Integrative Medicine (CSIR), Srinagar 190005, India.
Bioorganic Chemistry Division, Indian Institute of Integrative Medicine (CSIR), Srinagar 190005, India.
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1047-51. doi: 10.1016/j.bmcl.2014.01.018. Epub 2014 Jan 15.
A convenient and modular synthesis involving diastereoselective Michael addition followed by regioselective Huisgen 1,3-dipolar cycloaddition reaction was carried out to furnish 1,4-disubstituted-1,2,3-triazoles of Ludartin. This reaction scheme involving Michael addition followed by regioselective Huisgen 1,3-dipolar cycloaddition reaction leading to the formation of triazolyl analogs is being reported for the first time. All the triazolyl products were characterised using spectral data analysis. Sulphorhodamine B cytotoxicity screening of the resulting products against a panel of five human cancerous cell-lines revealed that few of the analogs display promising broad spectrum cytotoxic effect. Among all the synthesized compounds, only 3q displayed the best cytotoxic effect with IC50 values of 12, 11, 38, 39 and 8.5 μM but less than the standard Ludartin (1) with IC50 values of 6.3, 7.4, 7.5, 6.9 and 0.5 μM against human neuroblastoma (T98G), lung (A-549), prostate (PC-3), colon (HCT-116) and breast (MCF-7) cancer cell lines, respectively. The present synthesis was designed based on the previous literature reports of Ludartin as an aromatase inhibitor. Our work provides an initial study on structure-activity relationship of triazolyl analogs of sesquiterpene lactones in general and Ludartin (1) in particular.
一种方便且模块化的合成方法,涉及非对映选择性迈克尔加成,随后是区域选择性 Huisgen 1,3-偶极环加成反应,用于提供 Ludartin 的 1,4-二取代-1,2,3-三唑。首次报道了这种涉及迈克尔加成,随后是区域选择性 Huisgen 1,3-偶极环加成反应,导致三唑类似物形成的反应方案。所有三唑产物均通过光谱数据分析进行了表征。对一系列五种人类癌细胞系进行的 Sulphorhodamine B 细胞毒性筛选结果表明,几种类似物显示出有希望的广谱细胞毒性作用。在所合成的化合物中,只有 3q 显示出最好的细胞毒性作用,其 IC50 值分别为 12、11、38、39 和 8.5 μM,但低于标准 Ludartin(1),其对人神经母细胞瘤(T98G)、肺(A-549)、前列腺(PC-3)、结肠(HCT-116)和乳腺癌(MCF-7)的 IC50 值分别为 6.3、7.4、7.5、6.9 和 0.5 μM。本合成是基于 Ludartin 作为芳香酶抑制剂的先前文献报道设计的。我们的工作提供了对倍半萜内酯三唑类似物的结构-活性关系的初步研究,特别是对 Ludartin(1)的研究。